Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. Please see the Aims and Scope tab for further information.
This journal is a member of the Committee on Publication Ethics (COPE).
Why publish in Circulating Biomarkers?
- Expert international Editorial Board
- Rigorous peer review of your scholarly work
- Rapid online publication
Open access article processing charge (APC) information
The APC for this journal is currently an introductory rate of $1500 USD discounted from the full rate of $2000. This introductory rate is available for a limited time.
The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
Submit your manuscript today at http://mc.manuscriptcentral.com/jnlcb
Please see the Submission Guidelines tab for more information on how to submit your article to the journal.
Please direct any queries to Philippa.email@example.com
Journal of Circulating Biomarkers is an international, peer-reviewed, open access scientific journal focusing on all aspects of the rapidly growing field of circulating blood-based biomarkers and diagnostics using circulating protein and lipid markers, circulating tumor cells (CTC), circulating cell-free DNA (cfDNA) and extracellular vesicles, including exosomes, microvesicles, microparticles, ectosomes and apoptotic bodies. The journal publishes high-impact articles that deal with all fields related to circulating biomarkers and diagnostics, ranging from basic science to translational and clinical applications. Papers from a wide variety of disciplines are welcome; interdisciplinary studies are especially suitable for this journal.
Included within the scope are a broad array of specialties including (but not limited to) cancer, immunology, neurology, metabolic diseases, cardiovascular medicine, regenerative medicine, nosology, physiology, pathology, technological applications in diagnostics, therapeutics, vaccine, drug delivery, regenerative medicine, drug development and clinical trials. The journal also hosts reviews, perspectives and news on specific topics.
All submitted articles considered suitable for Journal of Circulating Biomarkers are subjected to rigorous peer review to ensure the highest levels of quality. The review process is carried out as quickly as possible to minimize any delays in the online publication of articles.
Submissions are encouraged from all institutions and on all topics related to circulation protein and lipid markers, CTC, cfDNA and extracellular vesicles, including:
- technical development and clinical application of circulating protein and lipid markers
- technical advances in isolation, purification and characterization of CTC, cfDNA, exosomes and other extracellular vesicles
- clinical applications of CTCs, circulating cell free DNA and extracellular vesicles
- use of CTCs, cfDNA, exosomes and extracellular vesicles in diagnostics and companion diagnostics
- use of extracellular vesicles in therapeutics delivery, antigen presentation and vaccine development
- design and production of cell-derived vesicles and synthetic vesicles
- biogenesis of extracellular vesicles, both in eukaryotic and prokaryotic cells
- mechanisms of vesicle: cell interactions intercellular signaling
- intercellular traffic of proteins, nucleic acids and other macromolecules
- modulation of the extracellular matrix
- roles of extracellular vesicles in normal physiological processes, including differentiation, development, immunity, tissue repair, stem cell biology, etc.
- roles of extracellular vesicles in disease, including cancer, neurodegeneration, diabetes, chronic inflammatory diseases, cardiovascular diseases, infectious disease, ageing, etc.
- virology and bacteriology
- use of extracellular vesicles in association with other synthetic nanoparticle for different scopes
|Prof. Winston Kuo||CloudHealth Genomics, Ltd., China|
|Hang Hubert Yin||University of Colorado Boulder, USA|
|Prof. Roger Chammas||Universidade de Sao Paulo, Brazil|
|Dr. Alain Charest||Harvard University Medical School, USA|
|Dr. Clark Chen||University of Minnesota Medical Center, USA|
|Dr. Stefano Fais||Istituto Superiore di Sanità (National Institute of Health), Italy|
|Ionita Ghiran||Beth Israel Deaconess Medical Center, USA|
|Dr. Daniel Haber||Massachusetts General Hospital Cancer Center, USA|
|Dr. Nancy Raab-Traub||University of North Carolina School of Medicine, USA|
|Prof. Lawrence Rajendran||University of Zurich, Switzerland|
|Dr. John Sinden||ReNeuron, UK|
|Dr. Johan Skog||Exosome Diagnostics, USA|
|Dr. David T. Wong||University of California-Los Angeles, USA|
|Dr. Alexander Vlassov||Thermo Fisher Scientific, USA|
|Dr. Leonora Balaj||Massachusetts General Hospital, USA|
|Pauline Carnell-Morris||Malvern Instruments Limited, UK|
|Dr Cesar Castro||Massachusetts General Hospital Cancer Center, USA|
|Chih Chen||National Tsing Hua University, Taiwan|
|Pui-Wah Choi||Arbele Ltd, Hong Kong|
|Dr. Emanuele Cocucci||Comprehensive Cancer Center, The Ohio State University, USA|
|Dr. Utkan Demirci||Stanford University, USA|
|Dr. Dolores Di Vizio||Harvard Medical School , USA|
|Jiang He||University of Virginia, USA|
|Dr. Stefan Holdenrieder||University of Bonn, Germany|
|Dr. Alexander Ivanov||Northeastern University, USA|
|Dr. Hongjun Kang||Tulane University, China|
|Dr. Shlomit Kenigsberg||CReATe Fertility Centre, Canada|
|Dr. Mehmet Kesimer||The University of North Carolina at Chapel Hill, USA|
|Dr Miroslaw Kornek||Saarland University, Germany|
|Prof. Masahiko Kuroda||Tokyo Medical University, Japan|
|Dr. Heedoo Lee||Pulmonary Center, Boston University of Medicine, USA|
|Dr. Marcis Leja||University of Latvia, Latvia|
|Dr. Sai-Kiang Lim||Institute of Medical Biology, Singapore|
|Dr. Aija Line||Latvian Biomedical Research and Study Centre, Riga, Latvia|
|Dr. Jan Lotvall||University of Gothenberg, Sweden|
|Dr. Todd Lowe||University of California – Santa Cruz, USA|
|Dr. Pierre-Yves Mantel||University of Fribourg, Switzerland|
|Dr. David Meckes||Florida State University, USA|
|Dr. Shannon Pendergrast||Ymir Genomics Ltd. USA|
|Dr. Eva Rohde||University Hospital Salzburg, Austria|
|Dr. Shivani Sharma||University of California-Los Angeles, USA|
|Dr. Zacharias Suntres||Northern Ontario School of Medicine, Canada|
|Yaoliang Tang||Augusta University, USA|
|Dr. John C Tigges||Beth Israel Deaconess Medical Center, USA|
|Dr Gareth Willis||Boston Children's Hospital, USA|
|Dr. Matthew J. Wood||University of Oxford, UK|
|Cindy Yamamoto||Hitachi Chemical Co. America, Ltd, USA|
|Hubert Yin||University of Colorado Boulder, USA|
|Dr. Bruce Zetter||Harvard Medical School , USA|
|Prof. Huang-ge Zhang||School of Medicine University of Louisville, USA|
|Dr. Hanyu Zhu||Chinese PLA General Hospital, China|